AU2003294249A8 - Hetero-substituted benzimidazole compounds and antiviral uses thereof - Google Patents

Hetero-substituted benzimidazole compounds and antiviral uses thereof

Info

Publication number
AU2003294249A8
AU2003294249A8 AU2003294249A AU2003294249A AU2003294249A8 AU 2003294249 A8 AU2003294249 A8 AU 2003294249A8 AU 2003294249 A AU2003294249 A AU 2003294249A AU 2003294249 A AU2003294249 A AU 2003294249A AU 2003294249 A8 AU2003294249 A8 AU 2003294249A8
Authority
AU
Australia
Prior art keywords
hetero
benzimidazole compounds
substituted benzimidazole
antiviral uses
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003294249A
Other versions
AU2003294249A1 (en
Inventor
John William Lackey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trimeris Inc
Original Assignee
Trimeris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trimeris Inc filed Critical Trimeris Inc
Publication of AU2003294249A8 publication Critical patent/AU2003294249A8/en
Publication of AU2003294249A1 publication Critical patent/AU2003294249A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003294249A 2002-11-08 2003-11-06 Hetero-substituted benzimidazole compounds and antiviral uses thereof Abandoned AU2003294249A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42494002P 2002-11-08 2002-11-08
US60/424,940 2002-11-08
PCT/US2003/035542 WO2004043913A2 (en) 2002-11-08 2003-11-06 Hetero-substituted benzimidazole compounds and antiviral uses thereof

Publications (2)

Publication Number Publication Date
AU2003294249A8 true AU2003294249A8 (en) 2004-06-03
AU2003294249A1 AU2003294249A1 (en) 2004-06-03

Family

ID=32312898

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003294249A Abandoned AU2003294249A1 (en) 2002-11-08 2003-11-06 Hetero-substituted benzimidazole compounds and antiviral uses thereof

Country Status (3)

Country Link
US (1) US20040166137A1 (en)
AU (1) AU2003294249A1 (en)
WO (1) WO2004043913A2 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06001669A (en) 2003-08-12 2006-04-28 3M Innovative Properties Co Oxime substituted imidazo-containing compounds.
US7897597B2 (en) 2003-08-27 2011-03-01 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
CA2548172A1 (en) 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
EP1701955A1 (en) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
EP1730143A2 (en) 2004-03-24 2006-12-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123079A2 (en) * 2004-06-14 2005-12-29 3M Innovative Properties Company Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
JP5313502B2 (en) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー Substituted chiral condensed [1,2] imidazo [4,5-c] cyclic compounds
JP2008528697A (en) * 2005-02-02 2008-07-31 ネクサスファーマ・インコーポレイテッド Compositions and methods containing amine derivatives for treating viral infections associated with cancer pathogenesis
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
JP2008530113A (en) 2005-02-11 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド Oxime and hydroxyramine substituted imidazo [4,5-c] ring compounds and methods
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
TWI370820B (en) 2005-04-27 2012-08-21 Takeda Pharmaceutical Fused heterocyclic compounds
US7884215B2 (en) * 2005-06-20 2011-02-08 Bonfanti Jean-Francois 2-substituted benzimidazoles
ATE532784T1 (en) 2006-02-17 2011-11-15 Pfizer Ltd 3-DEAZAPURINE DERIVATIVES AS TLR7 MODULATORS
ES2339298T3 (en) 2006-07-07 2010-05-18 Gilead Sciences, Inc. PIRIDAZINE NOVEDOUS COMPOUND AND USE OF IT.
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US8227603B2 (en) * 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
EP2995619B1 (en) * 2006-08-02 2019-09-25 Cytokinetics, Inc. Certain chemical entities comprising imidazopyrimidines, compositions and methods
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
WO2008023720A1 (en) * 2006-08-23 2008-02-28 Astellas Pharma Inc. Urea compound or salt thereof
US7851484B2 (en) * 2007-03-30 2010-12-14 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
DE102007037579B4 (en) * 2007-08-09 2012-05-16 Emc Microcollections Gmbh New benzimidazol-2-yl-alkylamines and their use as microbicidal agents
US7998976B2 (en) * 2008-02-04 2011-08-16 Cytokinetics, Inc. Certain chemical entities, compositions and methods
CN101983061A (en) * 2008-02-04 2011-03-02 赛特凯恩蒂克公司 Certain chemical entities, compositions and methods
NZ590688A (en) 2008-08-05 2012-09-28 Daiichi Sankyo Co Ltd imidazo[4,5-b]pyridin-2-one derivatives
EP3924343A1 (en) 2008-09-26 2021-12-22 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
TWI378933B (en) 2008-10-14 2012-12-11 Daiichi Sankyo Co Ltd Morpholinopurine derivatives
EP2348857B1 (en) 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US8563746B2 (en) 2008-10-29 2013-10-22 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
CA2741672A1 (en) 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
WO2010103306A1 (en) * 2009-03-10 2010-09-16 Astrazeneca Uk Limited Benzimidazole derivatives and their use as antivaral agents
JP2013520502A (en) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション Novel cyclic benzimidazole derivatives that are useful anti-diabetic drugs
UY33463A (en) 2010-06-24 2012-01-31 Takeda Pharmaceutical FUSED HETEROCYCLIC COMPOUNDS
ME02663B (en) 2010-10-06 2017-06-20 Glaxosmithkline Llc Benzimidazole derivatives as pi3 kinase inhibitors
TWI530495B (en) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 Benzimidazole respiratory syncytial virus inhibitors
TWI527814B (en) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 Azabenzimidazoles as respiratory syncytial virus antiviral agents
TWI515187B (en) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 Indoles as respiratory syncytial virus antiviral agents
TWI501967B (en) 2010-12-16 2015-10-01 Janssen R&D Ireland Azaindoles as respiratory syncytial virus antiviral agents
TWI541241B (en) 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 Imidazopyridines as respiratory syncytial virus antiviral agents
KR101951220B1 (en) 2011-07-13 2019-02-22 싸이토키네틱스, 인코포레이티드 Combination als therapy
KR102092612B1 (en) 2012-06-15 2020-03-25 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
EP2935253B1 (en) 2012-12-21 2018-08-01 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
JP6599852B2 (en) 2013-06-21 2019-10-30 ゼニス・エピジェネティクス・リミテッド Novel substituted bicyclic compounds as bromodomain inhibitors
ES2806135T3 (en) 2013-06-21 2021-02-16 Zenith Epigenetics Ltd New bicyclic bromodomain inhibitors
CN105593224B (en) 2013-07-31 2021-05-25 恒元生物医药科技(苏州)有限公司 Novel quinazolinones as bromodomain inhibitors
US10179125B2 (en) 2014-12-01 2019-01-15 Zenith Epigenetics Ltd. Substituted pyridines as bromodomain inhibitors
CA2966298A1 (en) 2014-12-01 2016-06-09 Zenith Epigenetics Ltd. Substituted pyridinones as bromodomain inhibitors
JP2017537946A (en) 2014-12-11 2017-12-21 ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． Substituted heterocycles as bromodomain inhibitors
CA2966450A1 (en) 2014-12-17 2016-06-23 Olesya KHARENKO Inhibitors of bromodomains
SI3240785T1 (en) 2014-12-29 2021-11-30 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
MX2021001186A (en) 2015-11-20 2022-10-11 Forma Therapeutics Inc Purinones as ubiquitin-specific protease 1 inhibitors.
TW201813963A (en) 2016-09-23 2018-04-16 美商基利科學股份有限公司 Phosphatidylinositol 3-kinase inhibitors
TW201825465A (en) 2016-09-23 2018-07-16 美商基利科學股份有限公司 Phosphatidylinositol 3-kinase inhibitors
TW201815787A (en) 2016-09-23 2018-05-01 美商基利科學股份有限公司 Phosphatidylinositol 3-kinase inhibitors
CN113952334B (en) * 2021-12-09 2024-04-30 复旦大学 Application of benzimidazole compound in preparation of anti-hepatitis B virus drugs
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors
CN117186187B (en) * 2023-07-12 2024-05-31 中国医学科学院病原生物学研究所 Anti-respiratory syncytial virus membrane fusion inhibitor and pharmaceutical application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3394141A (en) * 1965-11-12 1968-07-23 Fabio Sparatore Z-benzyaminobenzimidazoles
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5399580A (en) * 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
CA2168016C (en) * 1994-05-31 2000-09-26 Akio Matsunaga Benzimidazole derivatives
US5545653A (en) * 1995-06-07 1996-08-13 Eli Lilly And Company Anti-viral compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) * 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6774134B2 (en) * 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents

Also Published As

Publication number Publication date
WO2004043913A3 (en) 2004-09-23
WO2004043913A2 (en) 2004-05-27
US20040166137A1 (en) 2004-08-26
AU2003294249A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
AU2003294249A8 (en) Hetero-substituted benzimidazole compounds and antiviral uses thereof
EG24662A (en) Purine compounds and uses thereof
IL165810A0 (en) Novel benzimidazole derivatives
EP1646371A4 (en) Antiviral compounds and methods
GB0206048D0 (en) Use
GB0227666D0 (en) Use
GB0219947D0 (en) Conferencing system
AU2003202091A8 (en) Guanidine derivatives
GB0217056D0 (en) Use
GB0213878D0 (en) Use
GB0213765D0 (en) Admixture
GB0206838D0 (en) Use
AU2003304151A8 (en) Heteroaryl-ethanolamine derivatives as antiviral agents
GB0216702D0 (en) Webbing arrangement
GB0217572D0 (en) Portable devices for connection to the person
GB0230343D0 (en) Use
GB2388724B (en) Digtal-to-analogue convertor circuits
GB0206463D0 (en) Scaffolding clip
AU2002951855A0 (en) Benzimidazole antiviral agents
AU2003260462A8 (en) Rapid application integration
GB0229442D0 (en) Use
GB0215842D0 (en) Trestle
TW563768U (en) Quick joint structure
AU2002305470A1 (en) Benzimidazole compounds and antiviral uses thereof
CA94525S (en) Kneepad

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase